Some studies have suggested that the two models apply to different types of cancer, but patient data so far has been limited.Answering important clinical questions ??? such as whether genetic diversity is a risk factor for aggressive tumor development or how it relates to treatment resistance ??? requires analyzing samples from many patients with different types of cancer.